User contributions
From 2009.igem.org
(Latest | Earliest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)
- 03:04, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Project Management (top)
- 03:00, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Project Management
- 02:56, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Project Management
- 02:56, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Project Management
- 02:55, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Project Management
- 02:50, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Project Management
- 02:18, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks (top)
- 02:14, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 02:12, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 02:00, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 01:58, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 01:58, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 01:54, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 01:53, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 01:49, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Biobricks
- 00:30, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Material & Method (→Primers)
- 00:28, 22 October 2009 (diff | hist) Team:SupBiotech-Paris/Material & Method (→PCR (Promega Kit))
- 23:09, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Antitumor action (→Design of the fusion protein)
- 23:05, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Antitumor action (→Experimental approach)
- 22:55, 21 October 2009 (diff | hist) Team:SupBiotech-Paris/Antitumor action (→Context)
(Latest | Earliest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)